Search company, investor...

Executives

2

Board of Directors

3

Zyga Technology Management Team

2 Team Members

Zyga Technology has 2 executives. Zyga Technology's founder is Robert Assell. Zyga Technology's is .

Name

Work History

Title

Status

Robert Assell

Founder

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Robert Assell

Subscribe to see more

Work History

Title

Founder

Subscribe to see more

Status

Current

Subscribe to see more

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Zyga Technology Board of Directors

3 Board of directors

Zyga Technology has 3 board of directors, including David Stassen.

Name

Firm

Work History

Other Seats

David Stassen

Zyga Technology

Michael Sherman

Mike is an experienced scientist, manager, and company founder.Dr. Sherman&Atilde;&macr;&Acirc;&iquest;&Acirc;&frac12;carried out and/or supervised basic and applied research for almost twenty years at Hoffmann-La Roche, and managed drug discovery in three therapeutic areas.Since 1990, he has co-founded and served as the initial President of seven&Atilde;&macr;&Acirc;&iquest;&Acirc;&frac12;biotechnology companies, including PharmaGenics (sold to Genzyme Prostagen (sold to Cytogen Molecular Staging (sold to Qiagen Protometrix (sold to Invitrogen). Five of the companies Dr. Sherman has co-founded have been based at least in part on research conducted at Yale.In addition to extensive experience in fundraising for his companies, Dr. Sherman has established numerous corporate and academic relationships and helped to structure and negotiate a number of mergers.Mike has also served as consultant, advisor or director for a number of therapeutic, diagnostic, reagent, device, software, and investment companies, for academic institutions and for government agencies.Dr. Sherman is currently President and co-founder of Affomix Corporation, an Elm Street Ventures start-up.He is also Chairman of another Elm Street Ventures portofilo company, Iconic Therapeutics, Inc, of which he was a co-founder and the first president. He also&Atilde;&macr;&Acirc;&iquest;&Acirc;&frac12;serves on the Board of Directors of OncoMEDx, Inc.Following his undergraduate work at McGill University, Dr. Sherman received his PhD in molecular biology from the State University of New York and did postdoctoral studies at the University of Oxford. <input type=&quot;button&quot; value=&quot;Close Window&quot; onclick=&quot;window.

Zyga Technology

Nimesh Shah

Zyga Technology

Name

David Stassen

Michael Sherman

Nimesh Shah

Firm

Work History

Mike is an experienced scientist, manager, and company founder.Dr. Sherman&Atilde;&macr;&Acirc;&iquest;&Acirc;&frac12;carried out and/or supervised basic and applied research for almost twenty years at Hoffmann-La Roche, and managed drug discovery in three therapeutic areas.Since 1990, he has co-founded and served as the initial President of seven&Atilde;&macr;&Acirc;&iquest;&Acirc;&frac12;biotechnology companies, including PharmaGenics (sold to Genzyme Prostagen (sold to Cytogen Molecular Staging (sold to Qiagen Protometrix (sold to Invitrogen). Five of the companies Dr. Sherman has co-founded have been based at least in part on research conducted at Yale.In addition to extensive experience in fundraising for his companies, Dr. Sherman has established numerous corporate and academic relationships and helped to structure and negotiate a number of mergers.Mike has also served as consultant, advisor or director for a number of therapeutic, diagnostic, reagent, device, software, and investment companies, for academic institutions and for government agencies.Dr. Sherman is currently President and co-founder of Affomix Corporation, an Elm Street Ventures start-up.He is also Chairman of another Elm Street Ventures portofilo company, Iconic Therapeutics, Inc, of which he was a co-founder and the first president. He also&Atilde;&macr;&Acirc;&iquest;&Acirc;&frac12;serves on the Board of Directors of OncoMEDx, Inc.Following his undergraduate work at McGill University, Dr. Sherman received his PhD in molecular biology from the State University of New York and did postdoctoral studies at the University of Oxford. <input type=&quot;button&quot; value=&quot;Close Window&quot; onclick=&quot;window.

Other Seats

Zyga Technology

Zyga Technology

Zyga Technology

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Compare Zyga Technology to Competitors

N
NanoPowers

NanoPowers aims to develop artificial muscles for various implant indications. The Company has developed several animal proof of concepts, and is entering preclinical stages with devices aimed for the treatment of urinary and fecal incontinences.

V
Varix Medical

Varix Medical Corporation, located in Sunnyvale, Calif., is a medical device company focused on developing products for the minimally invasive treatment of chronic venous insufficiency, commonly referred to as "varicose veins." For patients with advanced stages of varicose veins, laser- and RF-based (radiofrequency) treatments have been developed, but each device has deficiencies making them less-than-optimal solutions. Varix Medical's platform technology will enable physicians to efficiently and effectively treat more types of diseased veins than is currently possible when using either laser or RF devices. Additional treatable vessels include tortuous sub-truncal vessels and other visible smaller varicose veins. The Varix platform employs a vapor-based endovenous ablation system that will consist of a disposable catheter, a catheter introducer or delivery system, and a reusable vapor generator. RCT and Coronis Medical Ventures LLC., formed Varix in August 2007 and acquired the technology under license from Tsunami MedTech LLC. Coronis and RCT have been the primary in investors in Varix.

MicroTransponder Logo
MicroTransponder

MicroTransponder operates as a global medical device company. It develops research-based neuroscience solutions. The company focuses on restoring independence and dignity for people suffering from neurological conditions to impair sensory and motor function. MicroTransponder was founded in 2007 and is based in Austin, Texas.

N
Neotonus

Neotonus is a medical device company which utilizes a non-invasive technology known as Extracorporeal Magnetic Innervation, or ExMI, initially targeted at urinary incontinence.

S
Spinal Restoration

Spinal Restoration focuses on innovative treatments for chronic low back pain within the healthcare sector. The company offers minimally invasive, early intervention therapies aimed at alleviating pain and promoting disc healing without the need for extensive surgery. Spinal Restoration primarily serves patients suffering from chronic back pain and healthcare providers looking for alternative treatment options. It was founded in 2004 and is based in Austin, Texas.

Ogenix Logo
Ogenix

Ogenix specializes in medical devices for wound care, focusing on oxygen therapy treatments. The company's flagship product, EPIFLO, offers a portable oxygen therapy solution that delivers concentrated oxygen directly to wounds to promote healing. EPIFLO is designed for continuous use, enhancing patient independence and potentially reducing overall treatment costs. It is based in Cleveland, Ohio.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.